Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$111M |
| 2 |
Ferguson
FERG
|
+$106M |
| 3 |
Apple
AAPL
|
+$103M |
| 4 |
Amazon
AMZN
|
+$103M |
| 5 |
Tesla
TSLA
|
+$75.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TIF
Tiffany & Co.
TIF
|
+$96.7M |
| 2 |
DuPont de Nemours
DD
|
+$51.9M |
| 3 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$43.4M |
| 4 |
AvalonBay Communities
AVB
|
+$36.1M |
| 5 |
Equity Residential
EQR
|
+$21.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.7% |
| 2 | Healthcare | 14.14% |
| 3 | Consumer Discretionary | 13.71% |
| 4 | Communication Services | 10.92% |
| 5 | Industrials | 9.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Krystal Biotech
KRYS
$9.72B
| $2.26M | ﹤0.01% |
29,300
+400
| +1% | +$29.1K |
|
1927
Omeros
OMER
$1.26B
| $2.26M | ﹤0.01% |
126,800
+1,500
| +1% | +$29.2K |
|
|
DBD
1928
DELISTED
Diebold Nixdorf Incorporated
DBD
| $2.26M | ﹤0.01% |
159,659
+1,300
| +0.8% | +$17.9K |
|
1929
RLX Technology
RLX
$2.44B
| $2.25M | ﹤0.01% |
+217,550
| New | +$4.18M |
|
1930
Impinj
PI
$5.46B
| $2.25M | ﹤0.01% |
39,600
+1,100
| +3% | +$64.8K |
|
1931
Chefs' Warehouse
CHEF
$4.57B
| $2.24M | ﹤0.01% |
73,400
+800
| +1% | +$23.8K |
|
1932
Smith & Wesson
SWBI
$643M
| $2.23M | ﹤0.01% |
127,750
+2,900
| +2% | +$52.7K |
|
|
DVAX
1933
DELISTED
Dynavax Technologies
DVAX
| $2.23M | ﹤0.01% |
226,578
+3,700
| +2% | +$30.5K |
|
1934
Kearny Financial
KRNY
$604M
| $2.22M | ﹤0.01% |
184,064
+1,900
| +1% | +$21.8K |
|
|
RDUS
1935
DELISTED
Radius Health, Inc.
RDUS
| $2.22M | ﹤0.01% |
106,400
+1,300
| +1% | +$27.4K |
|
1936
Children's Place
PLCE
$53.4M
| $2.21M | ﹤0.01% |
31,700
+400
| +1% | +$28K |
|
1937
QuinStreet
QNST
$1.19B
| $2.21M | ﹤0.01% |
108,800
+1,600
| +1% | +$36K |
|
|
NXGN
1938
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $2.21M | ﹤0.01% |
122,000
+1,400
| +1% | +$27.6K |
|
1939
Angi Inc
ANGI
$196M
| $2.2M | ﹤0.01% |
16,910
+1,100
| +7% | +$160K |
|
1940
Agilysys
AGYS
$3.25B
| $2.2M | ﹤0.01% |
45,800
+500
| +1% | +$24.9K |
|
|
RUBY
1941
DELISTED
Rubius Therapeutics, Inc
RUBY
| $2.2M | ﹤0.01% |
82,900
+10,000
| +14% | +$146K |
|
|
MCHB
1942
Mechanics Bancorp
MCHB
$3.79B
| $2.19M | ﹤0.01% |
49,800
-1,500
| -3% | -$62.4K |
|
1943
PagerDuty
PD
$932M
| $2.19M | ﹤0.01% |
54,500
+1,200
| +2% | +$54.8K |
|
1944
e.l.f. Beauty
ELF
$5.43B
| $2.19M | ﹤0.01% |
81,700
+1,400
| +2% | +$34.9K |
|
1945
National Healthcare
NHC
$3.44B
| $2.19M | ﹤0.01% |
28,130
+300
| +1% | +$21.2K |
|
|
TGI
1946
DELISTED
Triumph Group
TGI
| $2.19M | ﹤0.01% |
119,100
+1,400
| +1% | +$20.9K |
|
1947
Customers Bancorp
CUBI
$2.82B
| $2.18M | ﹤0.01% |
68,600
+700
| +1% | +$18.4K |
|
1948
RadNet
RDNT
$6.08B
| $2.18M | ﹤0.01% |
100,300
+1,200
| +1% | +$24.3K |
|
1949
Rackspace Technology
RXT
$1.1B
| $2.18M | ﹤0.01% |
91,600
+1,600
| +2% | +$34.5K |
|
1950
Preferred Bank
PFBC
$1.28B
| $2.17M | ﹤0.01% |
34,089
+700
| +2% | +$39.6K |
|
Similar funds
Swiss National Bank's Q1 2021 Portfolio in Review
As of Q1 2021, Swiss National Bank held 2,502 positions worth $150B, up 6.6% from $141B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 1.3%. Swiss National Bank opened 12 new positions and exited 20, leaving the 2,502-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q1 2021 buy was Ferguson: 872,392 shares worth $104M.
- Swiss National Bank added most to Microsoft in Q1 2021, an estimated $111M increase.
- Swiss National Bank's biggest Q1 2021 reduction was DuPont de Nemours, cutting an estimated $51.9M.
- Swiss National Bank fully exited Tiffany & Co. in Q1 2021, selling an estimated $96.7M.
- Swiss National Bank's ten largest holdings make up 23% of its $150B portfolio in Q1 2021.
- Swiss National Bank opened 12 new positions and closed 20 in Q1 2021.
- Swiss National Bank's portfolio value rose 6.6% quarter-over-quarter to $150B.
Based on Swiss National Bank's 13F filing for Q1 2021, filed 7 May 2021.